West Pharmaceutical Services (WST)
EBITDA Margin
25.83%
Quarterly · Period ending:
WST EBITDA Margin
Latest reported25.83%period ending
Latest reported25.83%period ending
WST Quarterly EBITDA Margin (100.00% → 25.83%)
Quarterly ebitda margin
High-resolution chart · PNG
WST ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 25.8283% | |
| 25.861% | |
| 26.0248% | |
| 26.9924% | |
| 25.9071% | |
| 21.6127% | |
| 27.4683% | |
| 27.5003% | |
| 24.0883% | |
| 23.6589% | |
| 28.029% | |
| 30.1806% | |
| 29.3821% | |
| 26.7775% | |
| 22.7837% | |
| 24.4901% | |
| 33.5796% | |
| 30.4432% | |
| 30.096% | |
| 30.116% | |
| 33.3656% | |
| 30.6706% | |
| 25.2111% | |
| 22.5971% | |
| 24.6916% | |
| 23.3055% | |
| 22.2269% | |
| 20.2282% | |
| 22.9655% | |
| 22.0167% | |
| 22.3301% | |
| 20.6625% | |
| 19.607% | |
| 19.678% | |
| 20.7452% | |
| 22.3281% | |
| 16.6415% | |
| 21.8154% | |
| 20.1727% | |
| 19.6443% | |
| 21.6753% | |
| 21.5686% | |
| 19.2383% | |
| 5.6313% | |
| 17.0698% | |
| 20.8395% | |
| 19.1252% | |
| 18.9379% | |
| 21.1982% | |
| 17.9354% | |
| 17.4497% | |
| 18.1685% | |
| 18.4615% | |
| 18.9157% | |
| 16.1742% | |
| 15.1745% | |
| 13.3621% | |
| 19.1906% | |
| 15.5044% | |
| 15.327% | |
| 15.3946% | |
| 16.4184% | |
| 9.2847% | |
| 16.1017% | |
| 10.8233% | |
| 17.0004% | |
| 13.7014% | |
| 17.1881% | |
| 17.3563% | |
| 15.0578% | |
| 18.3824% | |
| 13.1928% | |
| 20.9452% | |
| 19.8744% | |
| 19.6408% | |
| 5.3152% | |
| 13.2347% | |
| 15.3727% | |
| 14.9633% | |
| 9.0201% | |
| 13.3639% | |
| 12.6571% | |
| 16.7603% | |
| 14.3722% | |
| 16.9364% | |
| 13.4448% | |
| 20.8024% | |
| 11.0865% | |
| 17.4511% | |
| 16.018% | |
| 20.4114% | |
| 12.2398% | |
| 15.269% | |
| 12.3939% | |
| 15.1838% | |
| 14.2993% | |
| 16.8059% | |
| 19.865% | |
| 29.4466% | |
| 16.209% |